Results 11 to 20 of about 247,168 (212)

Fibroblast Activation Protein Targeted Near Infrared Photoimmunotherapy (NIR PIT) Overcomes Therapeutic Resistance in Human Esophageal Cancer [PDF]

open access: yesScientific Reports, 2021
Cancer-associated fibroblasts (CAFs) have an important role in the tumor microenvironment. CAFs have the multifunctionality which strongly support cancer progression and the acquisition of therapeutic resistance by cancer cells.
Shunsuke Kagawa   +2 more
exaly   +6 more sources

Disialoganglioside GD2-Targeted Near-Infrared Photoimmunotherapy (NIR-PIT) in Tumors of Neuroectodermal Origin [PDF]

open access: yesPharmaceutics, 2022
Disialoganglioside (GD2) is a subtype of glycolipids that is highly expressed in tumors of neuroectodermal origins, such as neuroblastoma and osteosarcoma.
Fuyuki F. Inagaki   +8 more
doaj   +3 more sources

CD29 Targeted Near-Infrared Photoimmunotherapy (NIR-PIT) in the Treatment of a Pigmented Melanoma Model [PDF]

open access: yesOncoImmunology, 2022
Near-infrared photoimmunotherapy (NIR-PIT) is a newly developed cancer treatment that utilizes an antibody-photoabsorber-conjugate (AbPC) combined with NIR light.
Hiroaki Wakiyama   +2 more
exaly   +3 more sources

Recent Advances in Localized Immunomodulation Technology: Application of NIR-PIT toward Clinical Control of the Local Immune System [PDF]

open access: yesPharmaceutics, 2023
Current immunotherapies aim to modulate the balance among different immune cell populations, thereby controlling immune reactions. However, they often cause immune overactivation or over-suppression, which makes them difficult to control.
Mizuki Yamada   +3 more
doaj   +3 more sources

EpCAM-Targeted Near-Infrared Photoimmunotherapy (NIR-PIT) for the Treatment of Breast Cancer [PDF]

open access: yesAnnals of Medicine
Background Near-infrared photoimmunotherapy (NIR-PIT) is a targeted cancer treatment that uses antibody-IR700 conjugates and selectively destroys cancer cells expressing a target antigen when exposed to near-infrared (NIR) light.
Aki Furusawa   +2 more
exaly   +4 more sources

Antibody Drug Conjugates of Near-Infrared Photoimmunotherapy (NIR-PIT) in Breast Cancers [PDF]

open access: yesTechnology in Cancer Research and Treatment, 2023
Worldwide, the incidence rate of breast cancer is the highest in women. Approximately 2.3 million people were newly diagnosed and 0.685 million were dead of breast cancer in 2020, which continues to grow.
Xiaosong Li, Cui Yingshu
exaly   +3 more sources

Near-Infrared Photoimmunotherapy (NIR-PIT) in Urologic Cancers [PDF]

open access: yesCancers, 2022
SIMPLE SUMMARY: Near-infrared photoimmunotherapy (NIR-PIT) is a novel molecularly-targeted therapy that induces rapid cancer cell death by systemically administering an antibody-photoabsorber conjugate (APC) that binds to cancer cells and irradiating NIR
Hiroshi Fukushima   +2 more
exaly   +3 more sources

Endoscopic Applications of Near-Infrared Photoimmunotherapy (NIR-PIT) in Cancers of the Digestive and Respiratory Tracts [PDF]

open access: yesBiomedicines, 2022
Near-infrared photoimmunotherapy (NIR-PIT) is a newly developed and promising therapy that specifically destroys target cells by irradiating antibody-photo-absorber conjugates (APCs) with NIR light.
Hiroaki Wakiyama   +2 more
exaly   +3 more sources

Near-Infrared Photoimmunotherapy (NIR-PIT) on Cholangiocarcinoma Using a Novel Catheter Device With Light Emitting Diodes [PDF]

open access: yesCancer Science, 2021
Near-infrared photoimmunotherapy (NIR-PIT) is a novel therapy for cancers that uses NIR light and antibody-photosensitizer (IR700) conjugates. However, it is difficult to deliver NIR light into the bile duct for cholangiocarcinoma (CCA) from the ...
Masaki Kuwatani   +2 more
exaly   +3 more sources

Near-InfraRed PhotoImmunoTherapy (NIR-PIT) for the Local Control of Solid Cancers: Challenges and Potentials for Human Applications [PDF]

open access: yesCritical Reviews in Oncology/Hematology, 2021
Near-InfraRed PhotoImmunoTherapy (NIR-PIT) is a novel cancer-targeted treatment effected by a chemical conjugation between a photosensitiser (e.g. the NIR phthalocyanine dye IRDye700DX) and a cancer-targeting moiety (e.g.
Marta Barisa   +2 more
exaly   +4 more sources

Home - About - Disclaimer - Privacy